SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

A recent study reveals that oxygen tension elevation during weeks four to six promotes neurogenesis in brain organoids, ...

President Trump is set to announce a trade deal with the UK Thursday, the first for his administration since imposing — then ...

Strategies to Remove Pre-Existing AAV Antibodies: IgG Enzymatic Degradation vs FcRn Inhibition. Presented by Yash Shah, PhD, ...